High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.

Abstract:

:Thirty-eight patients with previously treated Hodgkin's disease were given high dose combination chemotherapy using melphalan and BCNU and autologous bone marrow transplantation. In 25 patients etoposide was added in conventional dosage. During the course of the study the dose of melphalan was increased from 80 to 140 mg m-2 and the dose of BCNU from 300 to 600 mg m-2. The response rate was 76% with 53% complete remission. Forty-five per cent of the patients are free of disease at 4-20 months follow-up. There were eight (26%) treatment-related deaths due to lung damage (seven cases) and irreversible cardiac failure (one case). Fatal lung damage occurred only in patients receiving 600 mg m-2 of BCNU with high dose melphalan. The dose of BCNU given with high dose melphalan should not exceed 500 mg m-2. This treatment is effective against relapsed Hodgkin's disease but must be used cautiously. The best time for its use remains to be determined.

journal_name

Br J Cancer

authors

Zulian GB,Selby P,Milan S,Nandi A,Gore M,Forgeson G,Perren TJ,McElwain TJ

doi

10.1038/bjc.1989.128

subject

Has Abstract

pub_date

1989-04-01 00:00:00

pages

631-5

issue

4

eissn

0007-0920

issn

1532-1827

journal_volume

59

pub_type

杂志文章
  • Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

    abstract:BACKGROUND:Osteosarcoma (OS) is the most common primary bone tumour in children and adolescents. Patients who respond poorly to chemotherapy have a higher risk of metastatic disease and 5-year survival rates of only 10-20%. Therefore, identifying molecular targets that are specific for OS, or more specifically, metasta...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605723

    authors: Endo-Munoz L,Cumming A,Sommerville S,Dickinson I,Saunders NA

    更新日期:2010-06-29 00:00:00

  • Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score.

    abstract:BACKGROUND:Immunohistological assessment of Ki 67 expression is less expensive than Oncotype Dx, which is currently used to identify patients with lymph node-negative breast cancer, who will benefit from adjuvant chemotherapy. METHODS:The relationship of immunohistologically measured Ki 67 to Oncotype DX recurrence sc...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.402

    authors: Sahebjam S,Aloyz R,Pilavdzic D,Brisson ML,Ferrario C,Bouganim N,Cohen V,Miller WH Jr,Panasci LC

    更新日期:2011-10-25 00:00:00

  • High expression of N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma.

    abstract:BACKGROUND:Gestational trophoblastic diseases (GTDs) are related to trophoblasts, and human chorionic gonadotropin (hCG) is secreted by GTDs as well as normal placentas. However, the asparagine-linked sugar chains on hCG contain abnormal biantennary structures in invasive mole and choriocarcinoma, but not normal pregna...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.496

    authors: Niimi K,Yamamoto E,Fujiwara S,Shinjo K,Kotani T,Umezu T,Kajiyama H,Shibata K,Ino K,Kikkawa F

    更新日期:2012-12-04 00:00:00

  • Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer.

    abstract:BACKGROUND:Biomarkers for metastatic castration-resistant prostatic cancer (mCRPC) are an unmet medical need. METHODS:The prognostic and predictive value for survival and response to salvage hormonal therapy (SHT) of baseline testosterone level (TL) was analysed in a cohort of 101 mCRPC patients participating in 9 non...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2014.189

    authors: de Liaño AG,Reig O,Mellado B,Martin C,Rull EU,Maroto JP

    更新日期:2014-04-29 00:00:00

  • CSN6-TRIM21 axis instigates cancer stemness during tumorigenesis.

    abstract:BACKGROUND:Cancer stem cells (CSCs) are responsible for tumour initiation, metastasis and recurrence. However, the mechanism of CSC formation, maintenance and expansion in colorectal cancer (CRC) remains poorly characterised. METHODS:The role of COP9 signalosome subunit 6 (CSN6) in regulating cancer stemness was evalu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-020-0779-9

    authors: Qin B,Zou S,Li K,Wang H,Wei W,Zhang B,Xiao L,Choi HH,Tang Q,Huang D,Liu Q,Pan Q,Meng M,Fang L,Lee MH

    更新日期:2020-05-01 00:00:00

  • Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.

    abstract::There is increasing evidence that essential fatty acids (EFA) may have a role to play in the aetiology of some types of cancer although their precise mode of action is unknown. Differences in the metabolism of EFA between patients with benign or malignant prostatic disease may help to elucidate their role in the latte...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1991.481

    authors: Chaudry A,McClinton S,Moffat LE,Wahle KW

    更新日期:1991-12-01 00:00:00

  • A method for detecting carcinogenic organic chemicals using mammalian cells in culture.

    abstract::A method for testing organic chemicals for their carcinogenic potential is described. Baby hamster kidney cells (BHK-21/C1 13) were exposed to different doses of test compound in liquid tissue culture medium containing rat liver post-mitochondrial supernatant and cofactors (S-9 mix) to aid metabolism, but without seru...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1977.231

    authors: Styles JA

    更新日期:1977-11-01 00:00:00

  • Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study.

    abstract::The aim of the study was to evaluate efficacy and tolerance of epirubicin and gemcitabine as first-line chemotherapy in patients with advanced non-small-cell lung cancer. A phase I study was performed with the combination of escalating doses of epirubicin intravenously on day 1 and a fixed dose of gemcitabine on days ...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1054/bjoc.1999.1003

    authors: van Putten JW,Eppinga P,Erjavec Z,de Leede G,Nabers J,Smeets JB,Th Sleijfer D,Groen HJ

    更新日期:2000-02-01 00:00:00

  • Updated investigations of cancer excesses in individuals born or resident in the vicinity of Sellafield and Dounreay.

    abstract:BACKGROUND:Earlier studies have shown raised risks of leukaemia and non-Hodgkin lymphoma in children, teenagers and young adults resident either at birth or diagnosis in Seascale. Some increases in cancer risk in these age groups have also been noted among those living around Dounreay. We aimed to update previous analy...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2014.357

    authors: Bunch KJ,Vincent TJ,Black RJ,Pearce MS,McNally RJ,McKinney PA,Parker L,Craft AW,Murphy MF

    更新日期:2014-10-28 00:00:00

  • DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers.

    abstract::Oestrogen receptor alpha (ER-alpha) gene has two specific promoters, distal (P0) and proximal (P1), which induce almost identical transcripts in size due to different splicing. We examined the methylation at both promoter regions of the ER-alpha gene using HpaII, a methylation-sensitive restriction enzyme, prior to po...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6690631

    authors: Iwase H,Omoto Y,Iwata H,Toyama T,Hara Y,Ando Y,Ito Y,Fujii Y,Kobayashi S

    更新日期:1999-08-01 00:00:00

  • miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence.

    abstract:BACKGROUND:Radio- and chemotherapy (RT/CT) resistance hampers success in combating small and non-small cell lung cancers (SCLC/NSCLC). The underlying molecular mechanisms of RT/CT resistance of LCs are multifactorial and have been understood in part hitherto. miRNAs, key regulators of mRNAs, are well-recognised oncomir...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.382

    authors: Salim H,Akbar NS,Zong D,Vaculova AH,Lewensohn R,Moshfegh A,Viktorsson K,Zhivotovsky B

    更新日期:2012-10-09 00:00:00

  • Gene expression profiling identifies distinct molecular subgroups of leiomyosarcoma with clinical relevance.

    abstract:BACKGROUND:Soft tissue sarcomas are heterogeneous and a major complication in their management is that the existing classification scheme is not definitive and is still evolving. Leiomyosarcomas, a major histologic category of soft tissue sarcomas, are malignant tumours displaying smooth muscle differentiation. Althoug...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2016.280

    authors: Lee YF,Roe T,Mangham DC,Fisher C,Grimer RJ,Judson I

    更新日期:2016-10-11 00:00:00

  • Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.

    abstract:BACKGROUND:Regulator of cullins-1 (ROC1) is a key subunit in the cullin-RING ligase (CRL) protein complex. Our previous study indicated that ROC1 was essential for bladder cancer cell survival and that ROC1 knockdown inhibited CRL activity, triggering G2 phase arrest and senescence. However, the role of ROC1 in the mal...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2015.444

    authors: Wang W,Chen H,Liu Z,Qu P,Lan J,Chen H,Zou L,Qiu J

    更新日期:2016-02-02 00:00:00

  • Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion.

    abstract::The present study investigates the role of nitric oxide and the involvement of nitric oxide synthase II isoform on the invasion of human colorectal adenocarcinoma cell lines HRT-18 and HT-29. HRT-18 cells, which constitutively express nitric oxide synthase II mRNA were three-fold more invasive in a Matrigel invasion a...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600224

    authors: Siegert A,Rosenberg C,Schmitt WD,Denkert C,Hauptmann S

    更新日期:2002-04-22 00:00:00

  • Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.

    abstract:BACKGROUND:MYCN amplification with subsequent MYCN protein overexpression is a powerful indicator of poor prognosis of neuroblastoma patients. Little is known regarding the prognostic significance of the homologous MYC protein expression in neuroblastoma. METHODS:Immunostaining for MYCN and MYC protein was performed o...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2015.188

    authors: Wang LL,Teshiba R,Ikegaki N,Tang XX,Naranjo A,London WB,Hogarty MD,Gastier-Foster JM,Look AT,Park JR,Maris JM,Cohn SL,Seeger RC,Asgharzadeh S,Shimada H

    更新日期:2015-06-30 00:00:00

  • A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey.

    abstract::Secondary bile acids produced by the action of the colonic microflora may increase risk of colorectal cancer. Serum bile acid concentrations reflect the faecal bile acid profile and may be of value as biomarkers of risk of colorectal cancer. In a pilot investigation we examined: (i) the reproducibility of measurements...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600340

    authors: Costarelli V,Key TJ,Appleby PN,Allen DS,Fentiman IS,Sanders TA

    更新日期:2002-06-05 00:00:00

  • Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

    abstract::We have shown that doxorubicin entrapped in cardiolipin liposomes retain antitumour efficacy in mice but had diminished cardiac uptake and cardiotoxicity. Such liposomes are preferentially taken up by spleen. In a previous study we showed that a single dose of liposomal doxorubicin is not more toxic than free doxorubi...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1986.190

    authors: Rahman A,Joher A,Neefe JR

    更新日期:1986-09-01 00:00:00

  • Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

    abstract::The MIB-1 antibody has been raised against recombinant parts of the Ki-67 antigen and, unlike Ki-67, has wider application to routinely fixed specimens. The aim of this study was to compare the usefulness of MIB-1 with S-phase fraction (SPF) as a measure of proliferation. A total of 75 patients with operable breast ca...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1996.111

    authors: Ellis PA,Makris A,Burton SA,Titley J,Ormerod MG,Salter J,Powles TJ,Smith IE,Dowsett M

    更新日期:1996-03-01 00:00:00

  • Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.

    abstract:BACKGROUND:Vascular endothelial growth factor (VEGF)-mediated angiogenesis mediates tumour growth and metastasis. Meningiomas are primarily benign, slow-growing, highly vascularised tumours. Aside from VEGF, there is little data on the function of major angiogenic proteins in meningiomas. METHODS:The VEGFA, platelet-d...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2012.459

    authors: Pfister C,Pfrommer H,Tatagiba MS,Roser F

    更新日期:2012-11-06 00:00:00

  • MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer.

    abstract::We have established a novel ascites tumour model (MDA435/LCC6) from the oestrogen receptor-negative, invasive and metastatic MDA-MB-435 human breast cancer cell line. MDA435/LCC6 cells grow as both malignant ascites and solid tumours in vivo in nude mice and nude rats, with a tumour incidence of approximately 100%. Un...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1996.29

    authors: Leonessa F,Green D,Licht T,Wright A,Wingate-Legette K,Lippman J,Gottesman MM,Clarke R

    更新日期:1996-01-01 00:00:00

  • Guidelines for the welfare and use of animals in cancer research.

    abstract::Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer. Excellent standards of animal care are fully consistent with the conduct of high quality cancer research. Here we provide updated guidelines on th...

    journal_title:British journal of cancer

    pub_type: 杂志文章,实务指引

    doi:10.1038/sj.bjc.6605642

    authors: Workman P,Aboagye EO,Balkwill F,Balmain A,Bruder G,Chaplin DJ,Double JA,Everitt J,Farningham DA,Glennie MJ,Kelland LR,Robinson V,Stratford IJ,Tozer GM,Watson S,Wedge SR,Eccles SA,Committee of the National Cancer Researc

    更新日期:2010-05-25 00:00:00

  • Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma.

    abstract::Gain of 1q is one of the most common alterations in cancer and has been associated with adverse clinical behaviour in ependymoma. The aim of this study was to investigate this region to gain insight into the role of 1q genes in intracranial paediatric ependymoma. To address this issue we generated profiles of eleven e...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6604651

    authors: Rand V,Prebble E,Ridley L,Howard M,Wei W,Brundler MA,Fee BE,Riggins GJ,Coyle B,Grundy RG,Children's Cancer and Leukaemia Group Biological Studies Committee.

    更新日期:2008-10-07 00:00:00

  • Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases.

    abstract:BACKGROUND:To date, there are few reports on gene products contributing to colon cancer progression. METHODS:We used a gene trap comprised of an enhanced retroviral mutagen (ERM) cassette that includes a tetracycline-responsive promoter upstream of a haemagglutinin (HA) tag and a splice donor site. Integration of the ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6605536

    authors: Ishiguro T,Avila H,Lin SY,Nakamura T,Yamamoto M,Boyd DD

    更新日期:2010-02-16 00:00:00

  • Growth of human bronchial carcinomas in nude mice.

    abstract::Two hundred and thirteen lung tumours of primary site and 42 metastases were heterotransplanted into nude mice with an overall success rate of 44%. There were differences in success between the histological types. Squamous cell and adenocarcinoma had the highest success rate (51% and 43%, respectively) whereas large c...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1985.29

    authors: Mattern J,Jäger S,Sonka J,Wayss K,Volm M

    更新日期:1985-02-01 00:00:00

  • Testicular cancer in twins: a meta-analysis.

    abstract::In a meta-analysis of testicular cancer in twins, twins had a 30% increased risk (estimate 1.31, 95% CI 1.1-1.6), providing indirect support for the hypothesis that in utero hormone variations influence risk of testicular cancer. The summary-estimate for dizygotic twins was 1.3 (1.0-1.7) and for monozygotic or same se...

    journal_title:British journal of cancer

    pub_type: 杂志文章,meta分析

    doi:10.1038/sj.bjc.6604136

    authors: Neale RE,Carrière P,Murphy MF,Baade PD

    更新日期:2008-01-15 00:00:00

  • A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer.

    abstract::Protein kinase C (PKC) has a critical role in several signal transduction pathways, and is involved in renal cancer pathogenesis. Bryostatin-1 modulates PKC activity and has antitumour effects in preclinical studies. We conducted a multicentre phase II clinical trial in patients with advanced renal cancer to determine...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1038/sj.bjc.6601321

    authors: Madhusudan S,Protheroe A,Propper D,Han C,Corrie P,Earl H,Hancock B,Vasey P,Turner A,Balkwill F,Hoare S,Harris AL

    更新日期:2003-10-20 00:00:00

  • ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer.

    abstract:BACKGROUND:In colorectal cancer (CRC), BRAF mutations influence tumour progression. In mismatch repair-deficient (dMMR) tumours, BRAF mutations are associated with a good prognosis, whereas in MMR-competent tumours, they are detrimental. The differential expression of the downstream MAPK pathway members, which are cons...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-018-0174-y

    authors: Roseweir AK,Halcrow ES,Chichilo S,Powell AG,McMillan DC,Horgan PG,Edwards J

    更新日期:2018-08-01 00:00:00

  • Cancer risk in Swedish women: the relation to size at birth.

    abstract::The relationship between fetal growth as indicated by weight and length at birth, and cancer risk in 1080 adult Swedish women was examined. Birth factors were retrieved from original midwife records for the years 1914, 1918, 1922 and 1930, and primary cancer cases were identified by matching with national and regional...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2000.1738

    authors: Andersson SW,Bengtsson C,Hallberg L,Lapidus L,Niklasson A,Wallgren A,Hulthén L

    更新日期:2001-05-04 00:00:00

  • In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product.

    abstract::The c-erbB-2 product is thought to be a unique and useful target for antibody therapy of cancers overexpressing the c-erbB-2 gene. In vitro and in vivo anti-tumour effects of a humanised antibody against the extracellular domain of the c-erbB-2 gene product, rhu4D5, were examined. Rhu4D5 was less effective than its mu...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1996.259

    authors: Tokuda Y,Ohnishi Y,Shimamura K,Iwasawa M,Yoshimura M,Ueyama Y,Tamaoki N,Tajima T,Mitomi T

    更新日期:1996-06-01 00:00:00

  • Molecular alterations associated with liver metastases development in colorectal cancer patients.

    abstract:BACKGROUND:Understanding the molecular biology of colorectal cancer (CRC) provides opportunities for effective personalised patient management. We evaluated whether chromosomal aberrations, mutations in the PI(3)K signalling pathway and the CpG-island methylator phenotype (CIMP) in primary colorectal tumours can predic...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2011.184

    authors: Bruin SC,He Y,Mikolajewska-Hanclich I,Liefers GJ,Klijn C,Vincent A,Verwaal VJ,de Groot KA,Morreau H,van Velthuysen ML,Tollenaar RA,van 't Veer LJ

    更新日期:2011-07-12 00:00:00